ARTICLE | Company News
Max Planck Society, Vaxxilon deal
July 20, 2015 7:00 AM UTC
Max Planck and Actelion Ltd. (SIX:ATLN, Allschwil, Switzerland) launched Vaxxilon. The company has exclusive, worldwide rights to multiple preclinical vaccine candidates targeting undisclosed bacteri...